Founded in 2003 in honor of Kiona Tejan Jenkins, Kiona Foundation Inc. is a 501(c)(3) public charity conducting botanical drug discovery and IRB-registered research into the endocannabinoid system. The New York-based foundation follows the FDA Botanical Drug Development pathway, linking pharmacognosy with its Home for Hope research and cultivation campus in Wayne County, New York, and with Indigenous land partnerships across 11 international ecosystem nodes. Its active KF-ECS-2025 study seeks less toxic options for patients and families when conventional treatment has fallen short.
501(c)(3) Public Charity
OHRP Federal-Wide Assurance FWA00034558
Registration
IORG Registration IORG0012116
Registration
Independent Institutional Review Board Oversight
Compliance program
Neuropathix, IncFounded in 2010 through the creation of Kannalife Sciences, Neuropathix develops synthetic CBD-inspired therapeutics for neuroinflammation, neuropathic pain and neurodegenerative disease. Its lead compound, KLS-13019, is a globally patented non-opioid candidate being advanced from preclinical and IND-enabling research for chemotherapy-induced peripheral neuropathy, with research conducted at the Pennsylvania Biotechnology Center in Doylestown. The company’s scientific team brings more than 75 years of pharmaceutical research experience and holds more than 65 patents jointly.DOYLESTOWN, PA
Kannalife Sciences, IncFounded in 2010 and based at the Pennsylvania Biotechnology Center in Doylestown, Kannalife Sciences develops patented synthetic CBD-inspired therapeutics for neuroinflammation, neuropathic pain and neurodegenerative disease. Its lead investigational molecule, KLS-13019, is being advanced as a potential non-opioid treatment for chemotherapy-induced peripheral neuropathy, with research also examining Parkinson’s disease and other conditions linked to oxidative stress. Kannalife is a wholly owned Neuropathix subsidiary whose scientific team reports more than 75 years of combined pharmaceutical research experience and over 65 jointly held patents.DOYLESTOWN, PA
Terrapin Care StationFounded in Colorado in 2009, Terrapin Care Station grows and processes medical cannabis, now with a Pennsylvania-focused operation rooted in rural Clinton County. The independently owned, family-run company entered Pennsylvania in 2017 with one of the state’s first 12 grower/processor licenses and employs about 135 people at its facility. Terrapin is also known for its in-house breeding program and its “Flower to the People” approach, which pairs patient access with sustained support for local nonprofits and community initiatives.LEWISBURG, PA
SRIN TherapeuticsSRIN Therapeutics is advancing novel treatment options for patients by harnessing the power of the endocannabinoid system. The company focuses on biotechnology and pharmaceuticals.PHILADELPHIA, PA